Cargando…
Colchicine as a novel drug for the treatment of osteosarcoma through drug repositioning based on an FDA drug library
BACKGROUND: Colchicine is a traditional medication that is currently approved to treat gout and familial Mediterranean fever (FMF). However, colchicine has a wide range of anti-inflammatory activities, and several studies have indicated that it may be useful in a variety of other conditions, such as...
Autores principales: | Oh, Jisun, An, Hyun−Ju, Yeo, Hyun Jeong, Choi, Sujin, Oh, Jisu, Kim, Segi, Kim, Jin Man, Choi, Junwon, Lee, Soonchul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9433722/ https://www.ncbi.nlm.nih.gov/pubmed/36059694 http://dx.doi.org/10.3389/fonc.2022.893951 |
Ejemplares similares
-
miR-4284 Functions as a Tumor Suppressor in Renal Cell Carcinoma Cells by Targeting Glutamate Decarboxylase 1
por: Choi, Sujin, et al.
Publicado: (2023) -
Investigating drug repositioning opportunities in FDA drug labels through topic modeling
por: Bisgin, Halil, et al.
Publicado: (2012) -
Screening of Drug Repositioning Candidates for Castration Resistant Prostate Cancer
por: Kim, In-Wha, et al.
Publicado: (2019) -
Paradoxical Pro-angiogenic Effect of Low-Dose Ellipticine Identified by In Silico Drug Repurposing
por: Oh, Jisu, et al.
Publicado: (2021) -
Larval Zebrafish Model for FDA-Approved Drug Repositioning for Tobacco Dependence Treatment
por: Cousin, Margot A., et al.
Publicado: (2014)